🧪Trial version — For internal lab review only. Not for clinical or production use.
VaxIQ/Influenza (IIV/LAIV)
← Back to VaxIQ

Influenza (IIV/LAIV)

Influenza Vaccine (Inactivated and Live Attenuated)

Tier 1 · EPI/CoreVaccineCuration in progress

Platform: Inactivated / Live attenuated

Annual vaccine that protects against seasonal influenza, recommended for all individuals 6 months and older.

HAIOAShemagglutininannualage-stratified

Immunology Sections

Curated section analysis in progress

Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.

MechanismImmune ResponseMolecular & Immune SignaturesCorrelates of ProtectionOpen QuestionsImmunogenicitySafetyInfection Immunology

Wikipedia Overview

Full article ↗
Influenza vaccine

Influenza vaccines, colloquially known as flu shots or flu jab, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. Vaccination against influenza began in the 1930s, with large-scale availability in the United States beginning in 1945.

PubMed Literature

Search PubMed ↗

No PubMed results retrieved.

Semantic Scholar

Search S2 ↗

No Semantic Scholar results retrieved.